Global Personalized Precision Medicine Market Growth (Status and Outlook) 2024-2030

Global Personalized Precision Medicine Market Growth (Status and Outlook) 2024-2030

Personalized precision medicine is an important development direction in the medical field. It is expected to provide patients with more effective and safer treatment options and improve medical quality and patient satisfaction.

The global Personalized Precision Medicine market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Personalized Precision Medicine Industry Forecast” looks at past sales and reviews total world Personalized Precision Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Personalized Precision Medicine sales for 2023 through 2029. With Personalized Precision Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Personalized Precision Medicine industry.

This Insight Report provides a comprehensive analysis of the global Personalized Precision Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Personalized Precision Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Personalized Precision Medicine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Personalized Precision Medicine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Personalized Precision Medicine.

United States market for Personalized Precision Medicine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Personalized Precision Medicine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Personalized Precision Medicine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Personalized Precision Medicine players cover Agilent Technologies, Biogen, Johnson & Johnson, Boai NKY Pharmaceuticals Ltd., Novartis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Personalized Precision Medicine market by product type, application, key players and key regions and countries.

Segmentation by Type:
Gene Therapy
Personalized Medication
Health Management
Others

Segmentation by Application:
Tumors and Cancer
Cardiovascular Diseases
Genetic Disease
Autoimmune Disease
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Gene Therapy
Personalized Medication
Health Management
Others

Segmentation by Application:
Tumors and Cancer
Cardiovascular Diseases
Genetic Disease
Autoimmune Disease
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Agilent Technologies
Biogen
Johnson & Johnson
Boai NKY Pharmaceuticals Ltd.
Novartis
Pfizer
Roche
AstraZeneca
Sanofi
Amgen
Takeda Pharmaceutical
Merck
Eli Lilly
IQVIA
AbbVie
Parexel

Please note: The report will take approximately 2 business days to prepare and deliver.